• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

mBio. Hypervirulent Chlamydia trachomatis Clinical Strain Is a Recombinant between Lymphogranuloma Venereum (L2) and D Lineages

Giuseppe

Emeritus
[Source: mBio, full text: (LINK). Abstract, edited.]

Hypervirulent Chlamydia trachomatis Clinical Strain Is a Recombinant between Lymphogranuloma Venereum (L<SUB>2</SUB>) and D Lineages

  1. Naraporn Somboonna<SUP>a</SUP>*, 2 Raymond Wan<SUP>a</SUP>, 3 David M. Ojcius<SUP>b</SUP>, 4 Matthew A. Pettengill<SUP>b</SUP>, 5 Sandeep J. Joseph<SUP>c</SUP>, 6 Alexander Chang<SUP>d</SUP>, 7 Ray Hsu<SUP>a</SUP>, 8 Timothy D. Read<SUP>c,d</SUP>, and 9 Deborah Dean<SUP>a,e,f</SUP>
Author Affiliations
  1. Center for Immunobiology and Vaccine Development, Children?s Hospital Oakland, Research Institute, Oakland, California, USA<SUP>a</SUP>;
  2. Health Sciences Research Institute and School of Natural Sciences, University of California, Merced, Merced, California, USA<SUP>b</SUP>;
  3. Department of Medicine, Division of Infectious Diseases, Emory University School of Medicine, Atlanta, Georgia, USA<SUP>c</SUP>;
  4. Department of Human Genetics, Emory University School of Medicine, Atlanta, Georgia, USA<SUP>d</SUP>;
  5. Department of Medicine, University of California, San Francisco, San Francisco, California, USA<SUP>e</SUP>; and
  6. Joint Graduate Program in Bioengineering, University of California, Berkeley, Berkeley, California, USA<SUP>f</SUP>
Author Notes
  • ↵* Present address: Department of Microbiology, Faculty of Science, Chulalongkorn University, Bangkok, Thailand.
  1. Address correspondence to Deborah Dean, ddean@chori.org.
  1. Invited Editor Lee Ann Campbell, University of Washington Editor Stanley Maloy, San Diego State University
ABSTRACT


Chlamydia trachomatis is an obligate intracellular bacterium that causes a diversity of severe and debilitating diseases worldwide. Sporadic and ongoing outbreaks of lymphogranuloma venereum (LGV) strains among men who have sex with men (MSM) support the need for research on virulence factors associated with these organisms. Previous analyses have been limited to single genes or genomes of laboratory-adapted reference strain L<SUB>2</SUB>/434 and outbreak strain L<SUB>2</SUB>b/UCH-1/proctitis. We characterized an unusual LGV strain, termed L<SUB>2</SUB>c, isolated from an MSM with severe hemorrhagic proctitis. L<SUB>2</SUB>c developed nonfusing, grape-like inclusions and a cytotoxic phenotype in culture, unlike the LGV strains described to date. Deep genome sequencing revealed that L<SUB>2</SUB>c was a recombinant of L<SUB>2</SUB> and D strains with conserved clustered regions of genetic exchange, including a 78-kb region and a partial, yet functional, toxin gene that was lost with prolonged culture. Indels (insertions/deletions) were discovered in an ftsK gene promoter and in the tarp and hctB genes, which encode key proteins involved in replication, inclusion formation, and histone H1-like protein activity, respectively. Analyses suggest that these indels affect gene and/or protein function, supporting the in vitro and disease phenotypes. While recombination has been known to occur for C. trachomatis based on gene sequence analyses, we provide the first whole-genome evidence for recombination between a virulent, invasive LGV strain and a noninvasive common urogenital strain. Given the lack of a genetic system for producing stable C. trachomatis mutants, identifying naturally occurring recombinants can clarify gene function and provide opportunities for discovering avenues for genomic manipulation.


IMPORTANCE

Lymphogranuloma venereum (LGV) is a prevalent and debilitating sexually transmitted disease in developing countries, although there are significant ongoing outbreaks in Australia, Europe, and the United States among men who have sex with men (MSM). Relatively little is known about LGV virulence factors, and only two LGV genomes have been sequenced to date. We isolated an LGV strain from an MSM with severe hemorrhagic proctitis that was morphologically unique in tissue culture compared with other LGV strains. Bioinformatic and statistical analyses identified the strain as a recombinant of L<SUB>2</SUB> and D strains with highly conserved clustered regions of genetic exchange. The unique culture morphology and, more importantly, disease phenotype could be traced to the genes involved in recombination. The findings have implications for bacterial species evolution and, in the case of ongoing LGV outbreaks, suggest that recombination is a mechanism for strain emergence that results in significant disease pathology.

Footnotes

  • Citation Somboonna N, et al. 2011. Hypervirulent Chlamydia trachomatis clinical strain is a recombinant between lymphogranuloma venereum (L<SUB>2</SUB>) and D lineages. mBio 2(3):e00045-11. doi:10.1128/mBio.00045-11.
  • Received 20 March 2011
  • Accepted 13 April 2011
  • Published 3 May 2011
  • Copyright ? 2011 Somboonna et al.
This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported License, which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original author and source are credited.
- ------
 
Back
Top Bottom